Kodiak Sciences Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Operating income | -$234.4M | -$186.8M | -$277.3M | -$341.4M | -$267.1M |
| Operating expenses | $234.4M | $186.8M | $277.3M | $341.4M | $267.1M |
| Cash from operations | -$136.0M | -$117.3M | -$154.2M | -$206.5M | -$182.3M |
| Capital expenditure | $506,000 | $375,000 | $41.4M | $37.0M | $17.0M |
| Free cash flow | -$136.5M | -$117.7M | -$195.5M | -$243.5M | -$199.3M |
| Impairments | — | $0 | $0 | $0 | $0 |
| Total assets | $351.5M | $335.6M | $479.4M | $666.6M | $904.2M |
| Total liabilities | $194.2M | $185.3M | $213.6M | $230.5M | $240.9M |
Shares outstanding 62.6M · Free float 63.0%
Annual filing data through FY ended December 31, 2025; float as of July 13, 2026.